Effect of Dysmetabolisms and Comorbidities on the Efficacy and Safety of Biological Therapy in Chronic Inflammatory Joint Diseases

Effect of Dysmetabolisms and Comorbidities on the Efficacy and Safety of Biological Therapy in Chronic Inflammatory Joint Diseases

In the present study we evaluated how systemic arterial hypertension (SAH), dyslipidemia and diabetes mellitus influence the efficacy, safety and retention rate of biological disease-modifying anti-rheumatic drug (bDMARD) treatment in rheumatic musculoskeletal disorders (RMDs). The charts of RMD pat...

Full description

Bibliographic Details
Main Authors: Laura Cometi, Cosimo Bruni, Nicolò Chiti, Lorenzo Tofani, Francesca Nacci, Francesca Bartoli, Silvia Bellando-Randone, Daniela Melchiorre, Ginevra Fiori, Serena Guiducci, Marco Matucci-Cerinic
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:Journal of Clinical Medicine
Subjects:
arterial hypertension
dyslipidemia
bDMARDs
rheumatoid arthritis
psoriatic arthritis
ankylosing spondylitis
Online Access:https://www.mdpi.com/2077-0383/9/5/1310

Internet

https://www.mdpi.com/2077-0383/9/5/1310

Similar Items